baber/WOPTO huggingface dataset:
Patent CA-2313335-A1 (CA)
Title: An improved process scheme for processing sour feed in midw
Inventor: CHOU TAI-SHENG
IPC: C10G65/04
Filed: 1998-11-06
Abstract: This invention is directed to an improved process scheme to process sour feed in the reaction section of the process unit, including isomerization dewaxing with zeolite beta. The instant invention employs countercurrent flow in the fixed bed of the MIDW  (Mobil*Isomerization Dewaxing) reactor (the reactor in which isomerization dewaxing occurs) with recycle gas being the gas stream in the MIDW bed. With this arrangement hydrodesulfurization (HDS) and MIDW occur in an integrated process.
Patent CA-2315063-A1 (CA)
Title: Bleaching of chemical pulp with peracid
Inventor: JAKARA JUKKA
IPC: D21C9/10
Filed: 1998-12-18
Abstract: The invention relates to a process for the bleaching of chemical pulp and the use of a bleaching solution. According to the invention the pulp is treated in a plurality of different steps by using at least in one step a bleaching solution which contains a peracid, and the essential idea of the invention is that the peracid is used in a post-bleaching which is the last step of the bleaching process, the post bleaching being carried out in the presence of one or more earth-alkali metal compounds. By using a peracid the pulp is brought to its final brightness, and the purpose of the earth-alkali metal added is to combat the lowering of the viscosity of the pulp. According to the invention the post-bleaching can be carried out after the bleach plant steps in a pulp flow pipe, a storage tower or in the paper machine at a paper mill.
Patent CA-2317980-A1 (CA)
Inventor: ROY RADHIKA R
IPC: H04M3/56
Filed: 2000-09-08
Abstract: The present invention provides an H.323-based mobility system for real-time mobile multimedia communications and conferencing over packet-based networks. The H.323-based mobility system includes at least one H.323 Mobile Entity, arranged to send an H.323 call, that, upon detecting at least one H.323 mobility gatekeeper that-supports H.323 mobility services in a Location Area, communicates with a Home Location Databases moves from the first Location Area to a second Location Area, registers locally, and sets up a mobile H.323 based call; at least one Base Station, for receiving/sending the location information from/to a Mobile Switching Center, and for receiving/sending calls from/to the Mobile Switching Center for forwarding to a callee Mobile/Nonmobile Entity; the Home Location Database, arranged to receive and store Mobile Entity location information and send it to a first visitor Location Database, and upon the H.323 Mobile Entity moving from one Location Area to another Location Area, for receiving update location information and sending it to a second Visitor Location Database; the first Visitor Location Database, for storing and updating the location information; the first Mobile Switching Center, for, where the callee Mobile/Nonmobile Entity is in the first Location Area, setting up a call from the Mobile Entity to the callee Mobile/Nonmobile Entity, the second visitor Location Database, for storing and updating the location information; and the second Mobile Switching Center, for, where a callee Mobile/Nonmobile Entity is in the second Location Area, setting up a call from the Mobile Entity to the callee Mobile/Nonmobile Entity.
Patent CA-2318382-A1 (CA)
Title: Procede d'utilisation d'il-11 pour stimuler l'immunite induite par les cellules pour traiter des infections virales, parasitaires et le cancer
Inventor: O'TOOLE MARGOT
IPC: A61P31/12
Filed: 1999-01-12
Abstract: L'invention concerne des procédés de traitement de plusieurs maladies par la stimulation de l'activité des lymphocytes T cytotoxiques. Cette stimulation s'est avérée bénéfique pour les troubles viraux aigus, tels que la grippe, les troubles viraux chroniques, dont le virus Epstein-Barr (EBV), le virus de l'immunodéficience humaine (VIH), l'herpès, l'hépatite et le virus varicelle-zona, les infections parasitaires, notamment la malaria et la tuberculose, ainsi que le cancer. L'invention concerne, en outre, des procédés de stimulation ex vivo de l'activité de lymphocytes T des lymphocytes extraits de cellules dérivées de patients souffrant des troubles précités et de réintroduction dans le patient des cellules modifiées.
Patent CA-2318612-A1 (CA)
Title: Heat barrier composition, a mechanical superalloy article provided with a ceramic coating having such a composition, and a method of making the ceramic coating
Inventor: ARNAULT VERONIQUE
IPC: C23C30/00
Filed: 2000-09-06
Abstract: Thermal barrier composition is based on zirconia containing dysprosium oxide for stabilization and thermal conductivity reduction. A low thermal conductivity thermal barrier composition is based on zirconia containing dysprosium oxide, for stabilization and thermal conductivity reduction, and optionally an oxide of a tetravalent metal of atomic weight greater than that of zirconium. Independent claims are also included for: (i) a mechanical part of a superalloy having a ceramic coating of the above composition; and (ii) a method of forming a thermal barrier coating on a superalloy substrate by depositing the above composition on a bond layer on the substrate.
Patent CA-2321279-A1 (CA)
Title: Fiber sampling device
Inventor: FOODY PATRICK J
IPC: G01N33/34
Filed: 1999-02-23
Abstract: A device for obtaining a sample of fiber from an aqueous slurry of fiber flowing through a stock line (8), comprising a first isolation inlet valve element (5) together with a water supply orifice, located inside a fiber stock line; a second isolation valve means (4), and a third isolation valve (7), mounted in flow series from the sample inlet point on the stock line. This device allows a complete water purging down through the inlet valve element, as well as fiber samples to flow out of the stock line in the presence of diluent water. Samples flow from the first isolation valve means to a final collection point, without contamination or plugging.
Patent CA-2323703-A1 (CA)
Title: New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them
Inventor: LAVIELLE GILBERT
IPC: A61K31/395
Filed: 2000-10-12
Abstract: Cyano indoles (I), their enantiomers, diastereoisomers, and their salts with acids and bases, their preparation, and pharmaceutical compositions containing them. Cyano indoles of formula (I): R1 and R2 = H or 1-6C alkyl; T1 and T2 = 1-6C alkylene; G = a heterocyclic group of formula (a) or (b); W1, W2 and W3 = N, CR5, NR4 or CO; W4 = N, CR3, NR4, or CO; W5 = C or N; X1 = a bond, N, CR3 or NR4; X2 to X4 = CR3, NR4, CO, SR4, SO2, O, S, or N; R3 = H, halogen, 1-6C alkyl, OH, 1-6C perhaloalkyl, NO2, NH2, mono- or di alkylamino, or benzylamino; R4 = H, 1-6C alkyl, or optionally substituted aryl or aralkyl; and R5 = a group R3 or two adjacent groups R5 form, together with the C atoms to which they are attached, a saturated or unsaturated mono- or bicyclic group that may contain 1-5 O, N, or S hetero atoms and which may be substituted by R3 or oxo.
Patent CA-2325612-A1 (CA)
Title: Improvements in and relating to data transmission
Inventor: DEMETRESCU CRISTIAN
IPC: H04Q7/38
Filed: 2000-11-09
Abstract: A mobile telephone network operating general packet radio service includes a base station (2) and a group of mobile telephones (M1 to M8). The base station (2) includes a control unit which generates a succession of data packets which are transmitted along a common downlink to all the mobiles (M1 to M8).  Each data packet includes a header section containing an uplink state flag identifying a first selected mobile, to poll that mobile and cause it to return a packet of data to the base station along a common downlink channel. The header also includes an uplink state flag identifying a second selected mobile and is accompanied by the identity of and time slot for a second auxiliary uplink channel for polling the second mobile to cause the second mobile to return a packet of data to the base station along said auxiliary uplink channel thereby enabling the polling of at least two mobiles using the same data packet.
Patent CA-2326900-A1 (CA)
Inventor: CRAWLEY C M
IPC: E21B47/06
Filed: 2000-02-02
Abstract: Apparatus and methods for sensing one or more physical parameters at a remote location while minimizing or eliminating contact between reservoir fluids and the like at the remote location and the sensor used to sense the physical parameters.  In one embodiment the apparatus isolates the sensor within a tube containing the sensor.  Specifically, apparatus includes a tubing containing a communication cable and a sensor in communication with the cable, the sensor being located within the tubing proximate the remote location. A sealing device is configured to seal a section of the tubing containing the sensor from fluid flow within the tubing, the sealing device being configured to be actuated between a sealing state and a non-sealing state.
Patent CA-2327088-A1 (CA)
Inventor: COOPER BRIAN C
IPC: H04N5/44
Filed: 1999-03-31
Abstract: L'invention concerne un système d'édition vidéo non linéaire dont l'interface graphique utilisateur facilite la réalisation d'une composition par l'édition de vidéo-clips. Ledit système offre la possibilité d'afficher et d'éditer un cadre vidéo zone par zone. Chacune des zones peut être éditée séparément d'une autre zone de la même séquence. En outre, il est possible d'éliminer le sautillement inter-zone, qui se manifeste lorsque les zones sont affichées individuellement: il suffit de déterminer la zone qui comprenant la ligne de cadre supérieure et de procéder au réglage en conséquence.
Patent CA-2328045-A1 (CA)
Title: Device and method for treating water with ozone generated by water electrolysis
Inventor: SALAMA AMIR
IPC: C02F9/00
Filed: 2000-12-08
Abstract: A process and a device for the treatment of water, especially for removing therefrom a large variety of pollutants, especially organic, inorganic and biological pollutants through in situ generation of ozone. Ozone is economically produced in situ at a high concentration through the interaction of electrolytically produced oxygen and UV light having a wavelength of 189 nm. The device has a set of anode and cathode for electrolytically producing nascent oxygen which reacts with UV light at a wavelength of 189 nm to produce ozone "in situ " within a vessel where the polluted water is submitted to the combinative action of ozone and other oxidation reactions. The device also has a hydrocyclone or retention tank of removing cationic pollutants such as heavy metals, free radicals as well as undesirable electrolysis by-products such as nascent hydrogen through a secondary outlet. Oxidation by-products are subsequently removed from the exiting water stream by means of decantation, flocculation, coagulation or filtration.
Patent CA-2329217-A1 (CA)
Inventor: KOU JIM H
IPC: A61K9/20
Filed: 2000-12-20
Abstract: A film-coated extended release solid oral dosage composition containing a nasal decongestant, pseudoephedrine or salt thereof, e.g., pseudoephedrine sulfate in a core effective to provide a geometric maximum plasma concentration of pseudoephedrine of about 345 ng/mL to about 365 ng/mL at a time of about 7.60 hrs to about 8.40 hrs and having two or three film-coatings on thecore, the second one containing an amount of the non-sedating antihistamine, desloratadine, effective to provide a geometric maximum plasma concentration of desloratadine of about 2.15 ng/mL to about 2.45 ng/mL at a time of about 4.0 hours to about 4.5 hours, and use of the composition for treating patients showing the signs and symptoms associated with allergic and/or inflammatory conditions of the skin and airway passages are disclosed.
Patent CA-2330568-A1 (CA)
Title: Utilisation de derives de 4-piperidinemethanol dans le traitement de troubles neurologiques du developpement
Inventor: CARLSSON MARIA
IPC: A61K31/445
Filed: 1999-04-26
Abstract: L'invention concerne l'utilisation d'un composé correspondant à la formule (I) dans laquelle n est 2, 3 ou 4 et R¿1?, R¿2?, R¿3? et R¿4? sont chacun indépendamment hydrogène, alkyle C¿1?-C¿6?, halogène, trifluorométhyle, hydroxy, amino ou alcoxy C¿1?-C¿6? ou un isomère optique ou un sel pharmaceutiquement acceptable. Le composé est utilisé pour fabriquer une composition pharmaceutique destinée au traitement d'un trouble neurologique du développement. L'invention concerne également un procédé de traitement de troubles neurologiques du développement selon lequel une quantité thérapeutiquement efficace dudit composé est administrée à un patient.
Patent CA-2331139-A1 (CA)
Inventor: BETTIOL JEAN-LUC PHILIPPE
IPC: A01N63/02
Filed: 1999-04-30
Abstract: The present invention relates to a modified protein which comprises a catalytically active amino acid sequence of an antimicrobial enzyme and/or an amino acid sequence of an antimicrobial peptide, linked to an amino acid sequence comprising a Cellulose Binding Domain (CBD), and to laundry detergent and/or fabric care compositions comprising such modified proteins for improved sanitisation benefits.
Patent CA-2332126-A1 (CA)
Title: A novel human thrombopoietin mutein
Inventor: PARK SEUNG KOOK
IPC: A61K38/22
Filed: 1999-06-30
Abstract: The present invention relates to novel human thrombopoietin (; hTPO) derivatives, and to process of preparation thereof. Particularly, sugar chains are introduced into native hTPO by substituting amino acids such as asparagine for amino acids at specific positions in native hTPO, preparing novel hTPO  derivatives with high activities enhancing the platelet production in vivo. Therefore, the novel hTPO  derivatives of this invention may be useful for the treatment of thrombocytopenia associated with anticancer therapy or the transplantation of bone marrow.
Patent CA-2332146-A1 (CA)
Title: 24-hydroxyvitamin d, analogs and uses thereof
Inventor: STRUGNELL STEPHEN
IPC: A61K31/59
Filed: 1999-05-28
Abstract: The invention provides 24-hydroxyvitamin D compounds and their use in the treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders.
Patent CA-2332510-A1 (CA)
Inventor: HARRIS NICK S
IPC: C12Q1/6888
Filed: 1999-05-18
Abstract: La présente invention concerne un procédé permettant de détecter directement un fragment d'acide nucléique cible à partir d'un spécimen prélevé sur un patient par hybridation in situ. Ce procédé consiste dans la séquence d'opérations suivante. Un échantillon de spécimen est déposé sur une plaquette. Cet échantillon est fixé sur la plaquette au moyen d'un fixateur renfermant soit du méthanol-acide acétique, soit du formaldéhyde-acide acétique, dans les deux cas selon un rapport compris entre 99:1 et 80:20. Les acides nucléiques de l'échantillon sont mis en contact avec une sonde complexe spécifique du fragment d'acide nucléique dans des conditions d'hybridation convenables. Le complexe sonde non hybride est séparé de l'échantillon par rinçage. Après rinçage, l'échantillon est coloré au bleu d'Evans. Lorsque le complexe de sonde hybride est détecté visuellement au microscope, cela signifie que l'on se trouve en présence du fragment d'acide nucléique cible. Ce procédé peut être appliqué avec différents tampons d'hybridation, dont plusieurs font l'objet de la présente invention. Le procédé selon l'invention est utile pour la détection d'agents pathogènes de l'espèce Babesia. Il convient pour la détection d'acides nucléiques dans des spécimens nombreux et variés tels que sérum, plasma, crachat, urine, liquide céphalorachidien, tissus, lait maternel et insectes comme les tiques.
Patent CA-2332855-A1 (CA)
Title: Illuminating device for watches, gauges and similar devices
Inventor: FUWAUSA MICHELLE JILLIAN
IPC: G01D11/28
Filed: 2000-03-13
Abstract: A light source is positioned to direct light downward from the cover (12A) o f a conventional analog or electro-optical watch, indicator gauge, a meter pan el directional gauge or ornamentation display of an image, logo or design or other similar articles (1). These articles are illuminated by the source (12 ) for viewing in low light or in the dark by an illumination switch (6, 7) to activate said element. The light source (12) is preferably an LED and it is small enough so that when it is off, it is virtually invisible.
Patent CA-2335188-A1 (CA)
Inventor: BLESZYNSKI STANISLAW
IPC: G11B20/10
Filed: 2001-02-02
Abstract: Presented is a digital signal processing method for accurate detection of position and amplitude of digitized analog signals coming out of optical or magnetic pickup heads The least-square parametric fit of a second-or fourth-degree polynomial curve to 4 or more data points at a time, and minimization of the sum of square residuals allow for precise determination of peak top position and amplitude for the purpose of recording quality diagnostics. The method has been proven very reliable and noise-resistant.
Patent CA-2335528-A1 (CA)
Title: Novel compounds
Inventor: GREGOR VLAD
IPC: A61K51/04
Filed: 1999-06-16
Abstract: Compounds of general formula (I) are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain.
Patent CA-2336323-A1 (CA)
Title: Lithium bisoxalatoborate, the production thereof and its use as a conducting salt
Inventor: LISCHKA UWE
IPC: C07F5/04
Filed: 1999-06-07
Abstract: The invention relates to the novel lithium bisoxalatoborate compound, and to a method for producing this compound, on the basis of a lithium compound, an oxalic acid or an oxalate, and a boron compound. The invention also relates to another production method on the basis of lithium boron hydride and oxalic acid, and to the use of lithium bisoxalatoborate as a conducting salt in lithium-ion batteries.
Patent CA-2336480-A1 (CA)
Title: Method and apparatus for drying pulp
Inventor: SAIRANEN PAAVO
IPC: F26B17/20
Filed: 1999-06-21
Abstract: A fiber containing pulp, such as chemical pulp, mechanical pulp, thermomechanical pulp, TMP, de-inked water, or fiber containing sludge, is dried in an effective and efficient manner. The wet pulp is first dewatered mechanically, such as by using a drum or screw press. Then dewatered pulp is passed to a dryer. The dryer has first and second apertured cylindrical surfaces defining a gap between them, and drying gas is blown through one of the apertured surfaces, then through a pulp layer moving in the drying gap between the cylindrical surfaces, and then through the apertures in the other cylindrical surface, to evaporate water from the pulp and dry it to a dry matter content of over 80%, preferably about 85-90%.
Patent CA-2339253-A1 (CA)
Title: Inhibitors of p38
Inventor: BEMIS GUY
IPC: A61P35/00
Filed: 1999-09-16
Abstract: The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
Patent CA-2340227-A1 (CA)
Title: Method and pharmaceutical composition for reducing serum homocysteine concentration
Inventor: AMAGASE HARUNOBU
IPC: A61P9/00
Filed: 1999-01-13
Abstract: A method and composition are described for reducing the elevated plasma homocysteine level in mammals (humans) by oral administration of a therapeutically effective amount of Allium plants or extracts thereof, preferably garlic, with or without one or more vitamins such as B6, B12 and folic acid in an acceptable pharmaceutical carrier. Enhanced effectiveness is achieved with a combination of Allium plants or extracts thereof, preferably garlic, with vitamins such as B6, B12 and folic acid. The described method and composition are effective for prevention, treating or ameliorating cardiovascular diseases such as myocardial infarction, stroke and multiple arteriosclerosis by the reduction or prevention of high levels of plasma homocysteine, one of the major causes for such diseases. Methods and compositions are disclosed.
Patent CA-2343698-A1 (CA)
Title: Repair of larynx, trachea, and other fibrocartilaginous tissues
Inventor: SAMPATH KUBER T
IPC: A61L27/00
Filed: 1999-07-30
Abstract: Provided herein are methods and devices for inducing the formation of functional replacement nonarticular cartilage tissues and ligament tissues.  These methods and devices involve the use of osteogenic proteins, and are useful in repairing defects in the larynx, trachea, interarticular menisci, intervertebral discs, ear, nose, ribs and other fibrocartilaginous tissues in a mammal.
Patent CA-2344771-A1 (CA)
Title: High-voltage insulation system
Inventor: LAKNER MARTIN
IPC: H01F6/06
Filed: 2001-04-20
Abstract: The present invention relates to a high-voltage insulation system which is suitable for low temperatures and which, in addition to a cooling liquid (3) comprises a solid material insulator (2) based on a cellulose fabric (20). The solid material insulator (2) is preferably used in the form of pressboards and is impregnated with a polymer resin (21). It has a high partial discharge inception field of 77 K and, in addition, its thermal coefficient of expansion is optimally matched to that of ceramic high-temperature superconductors. The pressboards can be formed in the dry stage, in particular to produce coil formers, and are joined together alternately with cotton fabrics to form laminates of any desired thickness.
Patent CA-2345615-A1 (CA)
Inventor: MATSUI HIDEKI
IPC: C12N15/12
Filed: 1999-09-30
Abstract: A novel human-derived G protein-coupled receptor protein or a peptide fragment thereof; a nucleic acid encoding this receptor protein and its derivative, etc. The G protein-coupled receptor protein derived from human hippocampus or the nucleic acid encoding the same and its derivative are usable in determining a ligand (agonist) to the above G protein-coupled receptor protein, as preventives and/or remedies for diseases in association with the malfunction of the above G protein-coupled receptor protein, as gene diagnostics, in screening a compound capable of changing the expression dose of the receptor protein or its peptide fragment, etc.
Patent CA-2348978-A1 (CA)
Title: Portable type airborne microorganism sampler
Inventor: HATTA YUTAKA
IPC: C12M1/26
Filed: 1999-10-20
Abstract: A Petri dish (S) storing therein a culture medium (K) with a specified thickness is supported on the dish support (17) of a casing (14) and then a nozzle holding member (13) is fitted to the upper portion of the casing (14) . When a motor (19) is driven to rotate a high static pressure fan (18), air introduced through the hole (12a) of a nozzle (15) flows through the space between the nozzle (15) and the medium (K); a high trapping efficiency can b e then maintained with the distance between the medium and the nozzle set to 0 .5 to 1.5 mm.
Patent CA-2349518-A1 (CA)
Title: Trackable optical discs with concurrently readable analyte material
Inventor: WORTHINGTON MARK O
IPC: B01L3/00
Filed: 1999-10-26
Abstract: Design, manufacture and use of optical discs that permit the concurrent and discriminable acquisition of signals from both operational structures and nonoperational structures is presented. The disc geometries and tracking schemes permit such discs to be read in, and data encoded by nonoperational structures reported by, standard (or minimally-modified) optical disc readers.  Single data layer first and second surface discs are described, as are multiple data layer discs. Use of the discs in analyte-specific assay is presented.